MassiveID	filename	SampleType	SampleTypeSub1	NCBITaxonomy	AgeInYears	BiologicalSex	UBERONBodyPartName	TermsofPosition	HealthStatus	DOIDCommonName	ComorbidityListDOIDIndex	SampleCollectionDateandTime	Country	HumanPopulationDensity	LatitudeandLongitude	DepthorAltitudeMeters	ENVOEnvironmentBiome	ENVOEnvironmentMaterial	SubjectIdentifierAsRecorded	YearOfAnalysis	SampleCollectionMethod	SampleExtractionMethod	InternalStandardsUsed	MassSpectrometer	IonizationSourceAndPolarity	ChromatographyAndPhase	qiita_sample_name
MSV000084556	FD001_T1.mzXML	animal	biofluid	9606|Homo sapiens	60	female	feces		chronic illness	rheumatoid arthritis			United States of America		32.715736|-117.161087	19			FD001_T1	2019	solid material, fresh	methanol-water (1:1)	sulfamethazine	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)	
MSV000084556	FD001_T2.mzXML	animal	biofluid	9606|Homo sapiens	60	female	feces		chronic illness	rheumatoid arthritis			United States of America		32.715736|-117.161087	19			FD001_T2	2019	solid material, fresh	methanol-water (1:1)	sulfamethazine	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)	
MSV000084556	FD001_T3.mzXML	animal	biofluid	9606|Homo sapiens	60	female	feces		chronic illness	rheumatoid arthritis			United States of America		32.715736|-117.161087	19			FD001_T3	2019	solid material, fresh	methanol-water (1:1)	sulfamethazine	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)	
MSV000084556	FD002_T1.mzXML	animal	biofluid	9606|Homo sapiens	59	female	feces		chronic illness	rheumatoid arthritis			United States of America		32.715736|-117.161087	19			FD002_T1	2019	solid material, fresh	methanol-water (1:1)	sulfamethazine	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)	
MSV000084556	FD002_T2.mzXML	animal	biofluid	9606|Homo sapiens	59	female	feces		chronic illness	rheumatoid arthritis			United States of America		32.715736|-117.161087	19			FD002_T2	2019	solid material, fresh	methanol-water (1:1)	sulfamethazine	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)	
MSV000084556	FD002_T3.mzXML	animal	biofluid	9606|Homo sapiens	59	female	feces		chronic illness	rheumatoid arthritis			United States of America		32.715736|-117.161087	19			FD002_T3	2019	solid material, fresh	methanol-water (1:1)	sulfamethazine	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)	
MSV000084556	FD003_T1.mzXML	animal	biofluid	9606|Homo sapiens	57	female	feces		chronic illness	rheumatoid arthritis			United States of America		32.715736|-117.161087	19			FD003_T1	2019	solid material, fresh	methanol-water (1:1)	sulfamethazine	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)	
MSV000084556	FD003_T2.mzXML	animal	biofluid	9606|Homo sapiens	57	female	feces		chronic illness	rheumatoid arthritis			United States of America		32.715736|-117.161087	19			FD003_T2	2019	solid material, fresh	methanol-water (1:1)	sulfamethazine	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)	
MSV000084556	FD003_T3.mzXML	animal	biofluid	9606|Homo sapiens	57	female	feces		chronic illness	rheumatoid arthritis			United States of America		32.715736|-117.161087	19			FD003_T3	2019	solid material, fresh	methanol-water (1:1)	sulfamethazine	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)	
MSV000084556	FD004_T1.mzXML	animal	biofluid	9606|Homo sapiens	64	female	feces		chronic illness	rheumatoid arthritis			United States of America		32.715736|-117.161087	19			FD004_T1	2019	solid material, fresh	methanol-water (1:1)	sulfamethazine	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)	
MSV000084556	FD004_T2.mzXML	animal	biofluid	9606|Homo sapiens	64	female	feces		chronic illness	rheumatoid arthritis			United States of America		32.715736|-117.161087	19			FD004_T2	2019	solid material, fresh	methanol-water (1:1)	sulfamethazine	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)	
MSV000084556	FD004_T3.mzXML	animal	biofluid	9606|Homo sapiens	64	female	feces		chronic illness	rheumatoid arthritis			United States of America		32.715736|-117.161087	19			FD004_T3	2019	solid material, fresh	methanol-water (1:1)	sulfamethazine	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)	
MSV000084556	FD005_T1.mzXML	animal	biofluid	9606|Homo sapiens	63	female	feces		chronic illness	rheumatoid arthritis			United States of America		32.715736|-117.161087	19			FD005_T1	2019	solid material, fresh	methanol-water (1:1)	sulfamethazine	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)	
MSV000084556	FD005_T2.mzXML	animal	biofluid	9606|Homo sapiens	63	female	feces		chronic illness	rheumatoid arthritis			United States of America		32.715736|-117.161087	19			FD005_T2	2019	solid material, fresh	methanol-water (1:1)	sulfamethazine	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)	
MSV000084556	FD005_T3.mzXML	animal	biofluid	9606|Homo sapiens	63	female	feces		chronic illness	rheumatoid arthritis			United States of America		32.715736|-117.161087	19			FD005_T3	2019	solid material, fresh	methanol-water (1:1)	sulfamethazine	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)	
MSV000084556	FD006_T1.mzXML	animal	biofluid	9606|Homo sapiens	45	female	feces		chronic illness	rheumatoid arthritis			United States of America		32.715736|-117.161087	19			FD006_T1	2019	solid material, fresh	methanol-water (1:1)	sulfamethazine	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)	
MSV000084556	FD006_T2.mzXML	animal	biofluid	9606|Homo sapiens	45	female	feces		chronic illness	rheumatoid arthritis			United States of America		32.715736|-117.161087	19			FD006_T2	2019	solid material, fresh	methanol-water (1:1)	sulfamethazine	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)	
MSV000084556	FD006_T3.mzXML	animal	biofluid	9606|Homo sapiens	45	female	feces		chronic illness	rheumatoid arthritis			United States of America		32.715736|-117.161087	19			FD006_T3	2019	solid material, fresh	methanol-water (1:1)	sulfamethazine	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)	
MSV000084556	FD007_T1.mzXML	animal	biofluid	9606|Homo sapiens	57	female	feces		chronic illness	rheumatoid arthritis			United States of America		32.715736|-117.161087	19			FD007_T1	2019	solid material, fresh	methanol-water (1:1)	sulfamethazine	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)	
MSV000084556	FD007_T2.mzXML	animal	biofluid	9606|Homo sapiens	57	female	feces		chronic illness	rheumatoid arthritis			United States of America		32.715736|-117.161087	19			FD007_T2	2019	solid material, fresh	methanol-water (1:1)	sulfamethazine	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)	
MSV000084556	FD007_T3.mzXML	animal	biofluid	9606|Homo sapiens	57	female	feces		chronic illness	rheumatoid arthritis			United States of America		32.715736|-117.161087	19			FD007_T3	2019	solid material, fresh	methanol-water (1:1)	sulfamethazine	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)	
MSV000084556	FD010_T1.mzXML	animal	biofluid	9606|Homo sapiens	58	female	feces		chronic illness	rheumatoid arthritis			United States of America		32.715736|-117.161087	19			FD010_T1	2019	solid material, fresh	methanol-water (1:1)	sulfamethazine	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)	
MSV000084556	FD010_T2.mzXML	animal	biofluid	9606|Homo sapiens	58	female	feces		chronic illness	rheumatoid arthritis			United States of America		32.715736|-117.161087	19			FD010_T2	2019	solid material, fresh	methanol-water (1:1)	sulfamethazine	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)	
MSV000084556	FD010_T3.mzXML	animal	biofluid	9606|Homo sapiens	58	female	feces		chronic illness	rheumatoid arthritis			United States of America		32.715736|-117.161087	19			FD010_T3	2019	solid material, fresh	methanol-water (1:1)	sulfamethazine	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)	
MSV000084556	FD013_T1.mzXML	animal	biofluid	9606|Homo sapiens	33	female	feces		chronic illness	rheumatoid arthritis			United States of America		32.715736|-117.161087	19			FD013_T1	2019	solid material, fresh	methanol-water (1:1)	sulfamethazine	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)	
MSV000084556	FD013_T2.mzXML	animal	biofluid	9606|Homo sapiens	33	female	feces		chronic illness	rheumatoid arthritis			United States of America		32.715736|-117.161087	19			FD013_T2	2019	solid material, fresh	methanol-water (1:1)	sulfamethazine	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)	
MSV000084556	FD013_T3.mzXML	animal	biofluid	9606|Homo sapiens	33	female	feces		chronic illness	rheumatoid arthritis			United States of America		32.715736|-117.161087	19			FD013_T3	2019	solid material, fresh	methanol-water (1:1)	sulfamethazine	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)	
MSV000084556	FD017_T1.mzXML	animal	biofluid	9606|Homo sapiens	53	female	feces		chronic illness	rheumatoid arthritis			United States of America		32.715736|-117.161087	19			FD017_T1	2019	solid material, fresh	methanol-water (1:1)	sulfamethazine	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)	
MSV000084556	FD017_T2.mzXML	animal	biofluid	9606|Homo sapiens	53	female	feces		chronic illness	rheumatoid arthritis			United States of America		32.715736|-117.161087	19			FD017_T2	2019	solid material, fresh	methanol-water (1:1)	sulfamethazine	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)	
MSV000084556	FD017_T3.mzXML	animal	biofluid	9606|Homo sapiens	53	female	feces		chronic illness	rheumatoid arthritis			United States of America		32.715736|-117.161087	19			FD017_T3	2019	solid material, fresh	methanol-water (1:1)	sulfamethazine	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)	
MSV000084556	FD018_T1.mzXML	animal	biofluid	9606|Homo sapiens	71	female	feces		chronic illness	rheumatoid arthritis			United States of America		32.715736|-117.161087	19			FD018_T1	2019	solid material, fresh	methanol-water (1:1)	sulfamethazine	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)	
MSV000084556	FD018_T2.mzXML	animal	biofluid	9606|Homo sapiens	71	female	feces		chronic illness	rheumatoid arthritis			United States of America		32.715736|-117.161087	19			FD018_T2	2019	solid material, fresh	methanol-water (1:1)	sulfamethazine	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)	
MSV000084556	FD018_T3.mzXML	animal	biofluid	9606|Homo sapiens	71	female	feces		chronic illness	rheumatoid arthritis			United States of America		32.715736|-117.161087	19			FD018_T3	2019	solid material, fresh	methanol-water (1:1)	sulfamethazine	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)	
MSV000084556	FD019_T1.mzXML	animal	biofluid	9606|Homo sapiens	66	female	feces		chronic illness	rheumatoid arthritis			United States of America		32.715736|-117.161087	19			FD019_T1	2019	solid material, fresh	methanol-water (1:1)	sulfamethazine	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)	
MSV000084556	FD019_T2.mzXML	animal	biofluid	9606|Homo sapiens	66	female	feces		chronic illness	rheumatoid arthritis			United States of America		32.715736|-117.161087	19			FD019_T2	2019	solid material, fresh	methanol-water (1:1)	sulfamethazine	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)	
MSV000084556	FD019_T3.mzXML	animal	biofluid	9606|Homo sapiens	66	female	feces		chronic illness	rheumatoid arthritis			United States of America		32.715736|-117.161087	19			FD019_T3	2019	solid material, fresh	methanol-water (1:1)	sulfamethazine	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)	
MSV000084556	FD020_T1.mzXML	animal	biofluid	9606|Homo sapiens	69	male	feces		chronic illness	rheumatoid arthritis			United States of America		32.715736|-117.161087	19			FD020_T1	2019	solid material, fresh	methanol-water (1:1)	sulfamethazine	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)	
MSV000084556	FD020_T2.mzXML	animal	biofluid	9606|Homo sapiens	69	male	feces		chronic illness	rheumatoid arthritis			United States of America		32.715736|-117.161087	19			FD020_T2	2019	solid material, fresh	methanol-water (1:1)	sulfamethazine	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)	
MSV000084556	FD020_T3.mzXML	animal	biofluid	9606|Homo sapiens	69	male	feces		chronic illness	rheumatoid arthritis			United States of America		32.715736|-117.161087	19			FD020_T3	2019	solid material, fresh	methanol-water (1:1)	sulfamethazine	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)	
MSV000084556	FD022_T1.mzXML	animal	biofluid	9606|Homo sapiens	70	female	feces		chronic illness	rheumatoid arthritis			United States of America		32.715736|-117.161087	19			FD022_T1	2019	solid material, fresh	methanol-water (1:1)	sulfamethazine	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)	
MSV000084556	FD022_T2.mzXML	animal	biofluid	9606|Homo sapiens	70	female	feces		chronic illness	rheumatoid arthritis			United States of America		32.715736|-117.161087	19			FD022_T2	2019	solid material, fresh	methanol-water (1:1)	sulfamethazine	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)	
MSV000084556	FD022_T3.mzXML	animal	biofluid	9606|Homo sapiens	70	female	feces		chronic illness	rheumatoid arthritis			United States of America		32.715736|-117.161087	19			FD022_T3	2019	solid material, fresh	methanol-water (1:1)	sulfamethazine	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)	
MSV000084556	FD024_T1.mzXML	animal	biofluid	9606|Homo sapiens	74	female	feces		chronic illness	rheumatoid arthritis			United States of America		32.715736|-117.161087	19			FD024_T1	2019	solid material, fresh	methanol-water (1:1)	sulfamethazine	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)	
MSV000084556	FD024_T2.mzXML	animal	biofluid	9606|Homo sapiens	74	female	feces		chronic illness	rheumatoid arthritis			United States of America		32.715736|-117.161087	19			FD024_T2	2019	solid material, fresh	methanol-water (1:1)	sulfamethazine	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)	
MSV000084556	FD024_T3.mzXML	animal	biofluid	9606|Homo sapiens	74	female	feces		chronic illness	rheumatoid arthritis			United States of America		32.715736|-117.161087	19			FD024_T3	2019	solid material, fresh	methanol-water (1:1)	sulfamethazine	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)	
MSV000084556	FD026_T1.mzXML	animal	biofluid	9606|Homo sapiens	49	female	feces		chronic illness	rheumatoid arthritis			United States of America		32.715736|-117.161087	19			FD026_T1	2019	solid material, fresh	methanol-water (1:1)	sulfamethazine	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)	
MSV000084556	FD026_T2.mzXML	animal	biofluid	9606|Homo sapiens	49	female	feces		chronic illness	rheumatoid arthritis			United States of America		32.715736|-117.161087	19			FD026_T2	2019	solid material, fresh	methanol-water (1:1)	sulfamethazine	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)	
MSV000084556	FD026_T3.mzXML	animal	biofluid	9606|Homo sapiens	49	female	feces		chronic illness	rheumatoid arthritis			United States of America		32.715736|-117.161087	19			FD026_T3	2019	solid material, fresh	methanol-water (1:1)	sulfamethazine	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)	
MSV000084556	FD028_T1.mzXML	animal	biofluid	9606|Homo sapiens	29	female	feces		chronic illness	rheumatoid arthritis			United States of America		32.715736|-117.161087	19			FD028_T1	2019	solid material, fresh	methanol-water (1:1)	sulfamethazine	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)	
MSV000084556	FD028_T2.mzXML	animal	biofluid	9606|Homo sapiens	29	female	feces		chronic illness	rheumatoid arthritis			United States of America		32.715736|-117.161087	19			FD028_T2	2019	solid material, fresh	methanol-water (1:1)	sulfamethazine	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)	
MSV000084556	FD028_T3.mzXML	animal	biofluid	9606|Homo sapiens	29	female	feces		chronic illness	rheumatoid arthritis			United States of America		32.715736|-117.161087	19			FD028_T3	2019	solid material, fresh	methanol-water (1:1)	sulfamethazine	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)	
MSV000084556	PD001_T1.mzXML	animal	biofluid	9606|Homo sapiens	60	female	blood plasma		chronic illness	rheumatoid arthritis			United States of America		32.715736|-117.161087	19			PD001_T1	2019	blood draw, venous	methanol-water (1:1)	sulfamethazine	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)	
MSV000084556	PD001_T2.mzXML	animal	biofluid	9606|Homo sapiens	60	female	blood plasma		chronic illness	rheumatoid arthritis			United States of America		32.715736|-117.161087	19			PD001_T2	2019	blood draw, venous	methanol-water (1:1)	sulfamethazine	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)	
MSV000084556	PD001_T3.mzXML	animal	biofluid	9606|Homo sapiens	60	female	blood plasma		chronic illness	rheumatoid arthritis			United States of America		32.715736|-117.161087	19			PD001_T3	2019	blood draw, venous	methanol-water (1:1)	sulfamethazine	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)	
MSV000084556	PD002_T1.mzXML	animal	biofluid	9606|Homo sapiens	59	female	blood plasma		chronic illness	rheumatoid arthritis			United States of America		32.715736|-117.161087	19			PD002_T1	2019	blood draw, venous	methanol-water (1:1)	sulfamethazine	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)	
MSV000084556	PD002_T2.mzXML	animal	biofluid	9606|Homo sapiens	59	female	blood plasma		chronic illness	rheumatoid arthritis			United States of America		32.715736|-117.161087	19			PD002_T2	2019	blood draw, venous	methanol-water (1:1)	sulfamethazine	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)	
MSV000084556	PD002_T3.mzXML	animal	biofluid	9606|Homo sapiens	59	female	blood plasma		chronic illness	rheumatoid arthritis			United States of America		32.715736|-117.161087	19			PD002_T3	2019	blood draw, venous	methanol-water (1:1)	sulfamethazine	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)	
MSV000084556	PD003_T1.mzXML	animal	biofluid	9606|Homo sapiens	57	female	blood plasma		chronic illness	rheumatoid arthritis			United States of America		32.715736|-117.161087	19			PD003_T1	2019	blood draw, venous	methanol-water (1:1)	sulfamethazine	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)	
MSV000084556	PD003_T2.mzXML	animal	biofluid	9606|Homo sapiens	57	female	blood plasma		chronic illness	rheumatoid arthritis			United States of America		32.715736|-117.161087	19			PD003_T2	2019	blood draw, venous	methanol-water (1:1)	sulfamethazine	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)	
MSV000084556	PD003_T3.mzXML	animal	biofluid	9606|Homo sapiens	57	female	blood plasma		chronic illness	rheumatoid arthritis			United States of America		32.715736|-117.161087	19			PD003_T3	2019	blood draw, venous	methanol-water (1:1)	sulfamethazine	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)	
MSV000084556	PD004_T1.mzXML	animal	biofluid	9606|Homo sapiens	64	female	blood plasma		chronic illness	rheumatoid arthritis			United States of America		32.715736|-117.161087	19			PD004_T1	2019	blood draw, venous	methanol-water (1:1)	sulfamethazine	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)	
MSV000084556	PD004_T2.mzXML	animal	biofluid	9606|Homo sapiens	64	female	blood plasma		chronic illness	rheumatoid arthritis			United States of America		32.715736|-117.161087	19			PD004_T2	2019	blood draw, venous	methanol-water (1:1)	sulfamethazine	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)	
MSV000084556	PD004_T3.mzXML	animal	biofluid	9606|Homo sapiens	64	female	blood plasma		chronic illness	rheumatoid arthritis			United States of America		32.715736|-117.161087	19			PD004_T3	2019	blood draw, venous	methanol-water (1:1)	sulfamethazine	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)	
MSV000084556	PD005_T1.mzXML	animal	biofluid	9606|Homo sapiens	63	female	blood plasma		chronic illness	rheumatoid arthritis			United States of America		32.715736|-117.161087	19			PD005_T1	2019	blood draw, venous	methanol-water (1:1)	sulfamethazine	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)	
MSV000084556	PD005_T2.mzXML	animal	biofluid	9606|Homo sapiens	63	female	blood plasma		chronic illness	rheumatoid arthritis			United States of America		32.715736|-117.161087	19			PD005_T2	2019	blood draw, venous	methanol-water (1:1)	sulfamethazine	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)	
MSV000084556	PD005_T3.mzXML	animal	biofluid	9606|Homo sapiens	63	female	blood plasma		chronic illness	rheumatoid arthritis			United States of America		32.715736|-117.161087	19			PD005_T3	2019	blood draw, venous	methanol-water (1:1)	sulfamethazine	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)	
MSV000084556	PD006_T1.mzXML	animal	biofluid	9606|Homo sapiens	45	female	blood plasma		chronic illness	rheumatoid arthritis			United States of America		32.715736|-117.161087	19			PD006_T1	2019	blood draw, venous	methanol-water (1:1)	sulfamethazine	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)	
MSV000084556	PD006_T2.mzXML	animal	biofluid	9606|Homo sapiens	45	female	blood plasma		chronic illness	rheumatoid arthritis			United States of America		32.715736|-117.161087	19			PD006_T2	2019	blood draw, venous	methanol-water (1:1)	sulfamethazine	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)	
MSV000084556	PD006_T3.mzXML	animal	biofluid	9606|Homo sapiens	45	female	blood plasma		chronic illness	rheumatoid arthritis			United States of America		32.715736|-117.161087	19			PD006_T3	2019	blood draw, venous	methanol-water (1:1)	sulfamethazine	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)	
MSV000084556	PD007_T1.mzXML	animal	biofluid	9606|Homo sapiens	57	female	blood plasma		chronic illness	rheumatoid arthritis			United States of America		32.715736|-117.161087	19			PD007_T1	2019	blood draw, venous	methanol-water (1:1)	sulfamethazine	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)	
MSV000084556	PD007_T2.mzXML	animal	biofluid	9606|Homo sapiens	57	female	blood plasma		chronic illness	rheumatoid arthritis			United States of America		32.715736|-117.161087	19			PD007_T2	2019	blood draw, venous	methanol-water (1:1)	sulfamethazine	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)	
MSV000084556	PD007_T3.mzXML	animal	biofluid	9606|Homo sapiens	57	female	blood plasma		chronic illness	rheumatoid arthritis			United States of America		32.715736|-117.161087	19			PD007_T3	2019	blood draw, venous	methanol-water (1:1)	sulfamethazine	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)	
MSV000084556	PD010_T1.mzXML	animal	biofluid	9606|Homo sapiens	58	female	blood plasma		chronic illness	rheumatoid arthritis			United States of America		32.715736|-117.161087	19			PD010_T1	2019	blood draw, venous	methanol-water (1:1)	sulfamethazine	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)	
MSV000084556	PD010_T2.mzXML	animal	biofluid	9606|Homo sapiens	58	female	blood plasma		chronic illness	rheumatoid arthritis			United States of America		32.715736|-117.161087	19			PD010_T2	2019	blood draw, venous	methanol-water (1:1)	sulfamethazine	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)	
MSV000084556	PD010_T3.mzXML	animal	biofluid	9606|Homo sapiens	58	female	blood plasma		chronic illness	rheumatoid arthritis			United States of America		32.715736|-117.161087	19			PD010_T3	2019	blood draw, venous	methanol-water (1:1)	sulfamethazine	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)	
MSV000084556	PD013_T1.mzXML	animal	biofluid	9606|Homo sapiens	33	female	blood plasma		chronic illness	rheumatoid arthritis			United States of America		32.715736|-117.161087	19			PD013_T1	2019	blood draw, venous	methanol-water (1:1)	sulfamethazine	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)	
MSV000084556	PD013_T2.mzXML	animal	biofluid	9606|Homo sapiens	33	female	blood plasma		chronic illness	rheumatoid arthritis			United States of America		32.715736|-117.161087	19			PD013_T2	2019	blood draw, venous	methanol-water (1:1)	sulfamethazine	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)	
MSV000084556	PD013_T3.mzXML	animal	biofluid	9606|Homo sapiens	33	female	blood plasma		chronic illness	rheumatoid arthritis			United States of America		32.715736|-117.161087	19			PD013_T3	2019	blood draw, venous	methanol-water (1:1)	sulfamethazine	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)	
MSV000084556	PD015_T1.mzXML	animal	biofluid	9606|Homo sapiens	65	female	blood plasma		chronic illness	rheumatoid arthritis			United States of America		32.715736|-117.161087	19			PD015_T1	2019	blood draw, venous	methanol-water (1:1)	sulfamethazine	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)	
MSV000084556	PD015_T2.mzXML	animal	biofluid	9606|Homo sapiens	65	female	blood plasma		chronic illness	rheumatoid arthritis			United States of America		32.715736|-117.161087	19			PD015_T2	2019	blood draw, venous	methanol-water (1:1)	sulfamethazine	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)	
MSV000084556	PD015_T3.mzXML	animal	biofluid	9606|Homo sapiens	65	female	blood plasma		chronic illness	rheumatoid arthritis			United States of America		32.715736|-117.161087	19			PD015_T3	2019	blood draw, venous	methanol-water (1:1)	sulfamethazine	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)	
MSV000084556	PD016_T1.mzXML	animal	biofluid	9606|Homo sapiens	64	male	blood plasma		chronic illness	rheumatoid arthritis			United States of America		32.715736|-117.161087	19			PD016_T1	2019	blood draw, venous	methanol-water (1:1)	sulfamethazine	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)	
MSV000084556	PD016_T2.mzXML	animal	biofluid	9606|Homo sapiens	64	male	blood plasma		chronic illness	rheumatoid arthritis			United States of America		32.715736|-117.161087	19			PD016_T2	2019	blood draw, venous	methanol-water (1:1)	sulfamethazine	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)	
MSV000084556	PD016_T3.mzXML	animal	biofluid	9606|Homo sapiens	64	male	blood plasma		chronic illness	rheumatoid arthritis			United States of America		32.715736|-117.161087	19			PD016_T3	2019	blood draw, venous	methanol-water (1:1)	sulfamethazine	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)	
MSV000084556	PD017_T1.mzXML	animal	biofluid	9606|Homo sapiens	53	female	blood plasma		chronic illness	rheumatoid arthritis			United States of America		32.715736|-117.161087	19			PD017_T1	2019	blood draw, venous	methanol-water (1:1)	sulfamethazine	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)	
MSV000084556	PD017_T2.mzXML	animal	biofluid	9606|Homo sapiens	53	female	blood plasma		chronic illness	rheumatoid arthritis			United States of America		32.715736|-117.161087	19			PD017_T2	2019	blood draw, venous	methanol-water (1:1)	sulfamethazine	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)	
MSV000084556	PD017_T3.mzXML	animal	biofluid	9606|Homo sapiens	53	female	blood plasma		chronic illness	rheumatoid arthritis			United States of America		32.715736|-117.161087	19			PD017_T3	2019	blood draw, venous	methanol-water (1:1)	sulfamethazine	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)	
MSV000084556	PD018_T1.mzXML	animal	biofluid	9606|Homo sapiens	71	female	blood plasma		chronic illness	rheumatoid arthritis			United States of America		32.715736|-117.161087	19			PD018_T1	2019	blood draw, venous	methanol-water (1:1)	sulfamethazine	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)	
MSV000084556	PD018_T2.mzXML	animal	biofluid	9606|Homo sapiens	71	female	blood plasma		chronic illness	rheumatoid arthritis			United States of America		32.715736|-117.161087	19			PD018_T2	2019	blood draw, venous	methanol-water (1:1)	sulfamethazine	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)	
MSV000084556	PD018_T3.mzXML	animal	biofluid	9606|Homo sapiens	71	female	blood plasma		chronic illness	rheumatoid arthritis			United States of America		32.715736|-117.161087	19			PD018_T3	2019	blood draw, venous	methanol-water (1:1)	sulfamethazine	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)	
MSV000084556	PD019_T1.mzXML	animal	biofluid	9606|Homo sapiens	66	female	blood plasma		chronic illness	rheumatoid arthritis			United States of America		32.715736|-117.161087	19			PD019_T1	2019	blood draw, venous	methanol-water (1:1)	sulfamethazine	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)	
MSV000084556	PD019_T2.mzXML	animal	biofluid	9606|Homo sapiens	66	female	blood plasma		chronic illness	rheumatoid arthritis			United States of America		32.715736|-117.161087	19			PD019_T2	2019	blood draw, venous	methanol-water (1:1)	sulfamethazine	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)	
MSV000084556	PD019_T3.mzXML	animal	biofluid	9606|Homo sapiens	66	female	blood plasma		chronic illness	rheumatoid arthritis			United States of America		32.715736|-117.161087	19			PD019_T3	2019	blood draw, venous	methanol-water (1:1)	sulfamethazine	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)	
MSV000084556	PD020_T1.mzXML	animal	biofluid	9606|Homo sapiens	69	male	blood plasma		chronic illness	rheumatoid arthritis			United States of America		32.715736|-117.161087	19			PD020_T1	2019	blood draw, venous	methanol-water (1:1)	sulfamethazine	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)	
MSV000084556	PD020_T2.mzXML	animal	biofluid	9606|Homo sapiens	69	male	blood plasma		chronic illness	rheumatoid arthritis			United States of America		32.715736|-117.161087	19			PD020_T2	2019	blood draw, venous	methanol-water (1:1)	sulfamethazine	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)	
MSV000084556	PD020_T3.mzXML	animal	biofluid	9606|Homo sapiens	69	male	blood plasma		chronic illness	rheumatoid arthritis			United States of America		32.715736|-117.161087	19			PD020_T3	2019	blood draw, venous	methanol-water (1:1)	sulfamethazine	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)	
MSV000084556	PD021_T1.mzXML	animal	biofluid	9606|Homo sapiens	45	female	blood plasma		chronic illness	rheumatoid arthritis			United States of America		32.715736|-117.161087	19			PD021_T1	2019	blood draw, venous	methanol-water (1:1)	sulfamethazine	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)	
MSV000084556	PD021_T2.mzXML	animal	biofluid	9606|Homo sapiens	45	female	blood plasma		chronic illness	rheumatoid arthritis			United States of America		32.715736|-117.161087	19			PD021_T2	2019	blood draw, venous	methanol-water (1:1)	sulfamethazine	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)	
MSV000084556	PD021_T3.mzXML	animal	biofluid	9606|Homo sapiens	45	female	blood plasma		chronic illness	rheumatoid arthritis			United States of America		32.715736|-117.161087	19			PD021_T3	2019	blood draw, venous	methanol-water (1:1)	sulfamethazine	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)	
MSV000084556	PD022_T1.mzXML	animal	biofluid	9606|Homo sapiens	70	female	blood plasma		chronic illness	rheumatoid arthritis			United States of America		32.715736|-117.161087	19			PD022_T1	2019	blood draw, venous	methanol-water (1:1)	sulfamethazine	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)	
MSV000084556	PD022_T2.mzXML	animal	biofluid	9606|Homo sapiens	70	female	blood plasma		chronic illness	rheumatoid arthritis			United States of America		32.715736|-117.161087	19			PD022_T2	2019	blood draw, venous	methanol-water (1:1)	sulfamethazine	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)	
MSV000084556	PD022_T3.mzXML	animal	biofluid	9606|Homo sapiens	70	female	blood plasma		chronic illness	rheumatoid arthritis			United States of America		32.715736|-117.161087	19			PD022_T3	2019	blood draw, venous	methanol-water (1:1)	sulfamethazine	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)	
MSV000084556	PD024_T1.mzXML	animal	biofluid	9606|Homo sapiens	74	female	blood plasma		chronic illness	rheumatoid arthritis			United States of America		32.715736|-117.161087	19			PD024_T1	2019	blood draw, venous	methanol-water (1:1)	sulfamethazine	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)	
MSV000084556	PD024_T2.mzXML	animal	biofluid	9606|Homo sapiens	74	female	blood plasma		chronic illness	rheumatoid arthritis			United States of America		32.715736|-117.161087	19			PD024_T2	2019	blood draw, venous	methanol-water (1:1)	sulfamethazine	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)	
MSV000084556	PD024_T3.mzXML	animal	biofluid	9606|Homo sapiens	74	female	blood plasma		chronic illness	rheumatoid arthritis			United States of America		32.715736|-117.161087	19			PD024_T3	2019	blood draw, venous	methanol-water (1:1)	sulfamethazine	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)	
MSV000084556	PD026_T1.mzXML	animal	biofluid	9606|Homo sapiens	49	female	blood plasma		chronic illness	rheumatoid arthritis			United States of America		32.715736|-117.161087	19			PD026_T1	2019	blood draw, venous	methanol-water (1:1)	sulfamethazine	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)	
MSV000084556	PD026_T2.mzXML	animal	biofluid	9606|Homo sapiens	49	female	blood plasma		chronic illness	rheumatoid arthritis			United States of America		32.715736|-117.161087	19			PD026_T2	2019	blood draw, venous	methanol-water (1:1)	sulfamethazine	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)	
MSV000084556	PD026_T3.mzXML	animal	biofluid	9606|Homo sapiens	49	female	blood plasma		chronic illness	rheumatoid arthritis			United States of America		32.715736|-117.161087	19			PD026_T3	2019	blood draw, venous	methanol-water (1:1)	sulfamethazine	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)	
MSV000084556	PD028_T1.mzXML	animal	biofluid	9606|Homo sapiens	29	female	blood plasma		chronic illness	rheumatoid arthritis			United States of America		32.715736|-117.161087	19			PD028_T1	2019	blood draw, venous	methanol-water (1:1)	sulfamethazine	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)	
MSV000084556	PD028_T2.mzXML	animal	biofluid	9606|Homo sapiens	29	female	blood plasma		chronic illness	rheumatoid arthritis			United States of America		32.715736|-117.161087	19			PD028_T2	2019	blood draw, venous	methanol-water (1:1)	sulfamethazine	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)	
MSV000084556	PD028_T3.mzXML	animal	biofluid	9606|Homo sapiens	29	female	blood plasma		chronic illness	rheumatoid arthritis			United States of America		32.715736|-117.161087	19			PD028_T3	2019	blood draw, venous	methanol-water (1:1)	sulfamethazine	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)	
MSV000084556	flaxseeds.mzXML	food	food_source_complex	not applicable	not aplicable	not applicable	not applicable		not applicable	not applicable			United States of America		32.715736|-117.161087	19			flaxseeds	2019	solid material, fresh	methanol-water (1:1)	sulfamethazine	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)	
MSV000084556	ginger.mzXML	food	food_source_complex	not applicable	not aplicable	not applicable	not applicable		not applicable	not applicable			United States of America		32.715736|-117.161087	19			ginger	2019	solid material, fresh	methanol-water (1:1)	sulfamethazine	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)	
MSV000084556	miso.mzXML	food	food_source_complex	not applicable	not aplicable	not applicable	not applicable		not applicable	not applicable			United States of America		32.715736|-117.161087	19			miso	2019	solid material, fresh	methanol-water (1:1)	sulfamethazine	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)	
MSV000084556	oats.mzXML	food	food_source_complex	not applicable	not aplicable	not applicable	not applicable		not applicable	not applicable			United States of America		32.715736|-117.161087	19			oats	2019	solid material, fresh	methanol-water (1:1)	sulfamethazine	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)	
MSV000084556	almond_milk.mzXML	beverage	beverage_non_alcoholic	not applicable	not aplicable	not applicable	not applicable		not applicable	not applicable			United States of America		32.715736|-117.161087	19			almond_milk	2019	liquid	methanol-water (1:1)	sulfamethazine	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)	
MSV000084556	black_pepper.mzXML	food	food_source_complex	not applicable	not aplicable	not applicable	not applicable		not applicable	not applicable			United States of America		32.715736|-117.161087	19			black_pepper	2019	solid material, fresh	methanol-water (1:1)	sulfamethazine	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)	
MSV000084556	bread.mzXML	food	food_source_complex	not applicable	not aplicable	not applicable	not applicable		not applicable	not applicable			United States of America		32.715736|-117.161087	19			bread	2019	solid material, fresh	methanol-water (1:1)	sulfamethazine	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)	
MSV000084556	chia.mzXML	food	food_source_complex	not applicable	not aplicable	not applicable	not applicable		not applicable	not applicable			United States of America		32.715736|-117.161087	19			chia	2019	solid material, fresh	methanol-water (1:1)	sulfamethazine	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)	
MSV000084556	sesame.mzXML	food	food_source_complex	not applicable	not aplicable	not applicable	not applicable		not applicable	not applicable			United States of America		32.715736|-117.161087	19			sesame	2019	solid material, fresh	methanol-water (1:1)	sulfamethazine	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)	
MSV000084556	tahini.mzXML	food	food_source_complex	not applicable	not aplicable	not applicable	not applicable		not applicable	not applicable			United States of America		32.715736|-117.161087	19			tahini	2019	solid material, fresh	methanol-water (1:1)	sulfamethazine	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)	
MSV000084556	turmeric.mzXML	food	food_source_complex	not applicable	not aplicable	not applicable	not applicable		not applicable	not applicable			United States of America		32.715736|-117.161087	19			turmeric	2019	solid material, fresh	methanol-water (1:1)	sulfamethazine	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)	
MSV000084556	vinegar.mzXML	beverage	beverage_non_alcoholic	not applicable	not aplicable	not applicable	not applicable		not applicable	not applicable			United States of America		32.715736|-117.161087	19			vinegar	2019	liquid	methanol-water (1:1)	sulfamethazine	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)	
MSV000084556	6Mix_1.mzXML	blank_QC	blank_QC	not applicable	not aplicable	not applicable	not applicable		not applicable	not applicable			United States of America		32.715736|-117.161087	19			6Mix_1	2019	not applicable	methanol-water (1:1)	sulfamethazine	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)	
MSV000084556	6Mix_2.mzXML	blank_QC	blank_QC	not applicable	not aplicable	not applicable	not applicable		not applicable	not applicable			United States of America		32.715736|-117.161087	19			6Mix_2	2019	not applicable	methanol-water (1:1)	sulfamethazine	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)	
MSV000084556	Blank_1.mzXML	blank_extraction	blank_extraction	not applicable	not aplicable	not applicable	not applicable		not applicable	not applicable			United States of America		32.715736|-117.161087	19			Blank_1	2019	not applicable	methanol-water (1:1)	sulfamethazine	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)	
MSV000084556	Blank_1_20191103110310.mzXML	blank_extraction	blank_extraction	not applicable	not aplicable	not applicable	not applicable		not applicable	not applicable			United States of America		32.715736|-117.161087	19			Blank_1_20191103110310	2019	not applicable	methanol-water (1:1)	sulfamethazine	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)	
MSV000084556	Blank_2.mzXML	blank_extraction	blank_extraction	not applicable	not aplicable	not applicable	not applicable		not applicable	not applicable			United States of America		32.715736|-117.161087	19			Blank_2	2019	not applicable	methanol-water (1:1)	sulfamethazine	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)	
MSV000084556	Blank_2_20191103020736.mzXML	blank_extraction	blank_extraction	not applicable	not aplicable	not applicable	not applicable		not applicable	not applicable			United States of America		32.715736|-117.161087	19			Blank_2_20191103020736	2019	not applicable	methanol-water (1:1)	sulfamethazine	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)	
MSV000084556	Blank_2_20191103161240.mzXML	blank_extraction	blank_extraction	not applicable	not aplicable	not applicable	not applicable		not applicable	not applicable			United States of America		32.715736|-117.161087	19			Blank_2_20191103161240	2019	not applicable	methanol-water (1:1)	sulfamethazine	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)	
MSV000084556	Blank_3.mzXML	blank_extraction	blank_extraction	not applicable	not aplicable	not applicable	not applicable		not applicable	not applicable			United States of America		32.715736|-117.161087	19			Blank_3	2019	not applicable	methanol-water (1:1)	sulfamethazine	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)	
MSV000084556	Blank_4.mzXML	blank_extraction	blank_extraction	not applicable	not aplicable	not applicable	not applicable		not applicable	not applicable			United States of America		32.715736|-117.161087	19			Blank_4	2019	not applicable	methanol-water (1:1)	sulfamethazine	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)	
MSV000084556	Blanklcms_1.mzXML	blank_analysis	blank_analysis	not applicable	not aplicable	not applicable	not applicable		not applicable	not applicable			United States of America		32.715736|-117.161087	19			Blanklcms_1	2019	not applicable	not specified	none	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)	
MSV000084556	Blanklcms_2.mzXML	blank_analysis	blank_analysis	not applicable	not aplicable	not applicable	not applicable		not applicable	not applicable			United States of America		32.715736|-117.161087	19			Blanklcms_2	2019	not applicable	not specified	none	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)	
MSV000084556	Blanklcms_2a.mzXML	blank_analysis	blank_analysis	not applicable	not aplicable	not applicable	not applicable		not applicable	not applicable			United States of America		32.715736|-117.161087	19			Blanklcms_2a	2019	not applicable	not specified	none	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)	
MSV000084556	Blanklcms_2b.mzXML	blank_analysis	blank_analysis	not applicable	not aplicable	not applicable	not applicable		not applicable	not applicable			United States of America		32.715736|-117.161087	19			Blanklcms_2b	2019	not applicable	not specified	none	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)	
MSV000084556	Blanklcms_2c.mzXML	blank_analysis	blank_analysis	not applicable	not aplicable	not applicable	not applicable		not applicable	not applicable			United States of America		32.715736|-117.161087	19			Blanklcms_2c	2019	not applicable	not specified	none	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)	
MSV000084556	Blanklcms_2e.mzXML	blank_analysis	blank_analysis	not applicable	not aplicable	not applicable	not applicable		not applicable	not applicable			United States of America		32.715736|-117.161087	19			Blanklcms_2e	2019	not applicable	not specified	none	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)	
MSV000084556	Blanklcms_2f.mzXML	blank_analysis	blank_analysis	not applicable	not aplicable	not applicable	not applicable		not applicable	not applicable			United States of America		32.715736|-117.161087	19			Blanklcms_2f	2019	not applicable	not specified	none	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)	
MSV000084556	Blanklcms_2g.mzXML	blank_analysis	blank_analysis	not applicable	not aplicable	not applicable	not applicable		not applicable	not applicable			United States of America		32.715736|-117.161087	19			Blanklcms_2g	2019	not applicable	not specified	none	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)	
MSV000084556	Blanklcms_2h.mzXML	blank_analysis	blank_analysis	not applicable	not aplicable	not applicable	not applicable		not applicable	not applicable			United States of America		32.715736|-117.161087	19			Blanklcms_2h	2019	not applicable	not specified	none	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)	
MSV000084556	Blanklcms_3.mzXML	blank_analysis	blank_analysis	not applicable	not aplicable	not applicable	not applicable		not applicable	not applicable			United States of America		32.715736|-117.161087	19			Blanklcms_3	2019	not applicable	not specified	none	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)	
MSV000084556	Blanklcms_4.mzXML	blank_analysis	blank_analysis	not applicable	not aplicable	not applicable	not applicable		not applicable	not applicable			United States of America		32.715736|-117.161087	19			Blanklcms_4	2019	not applicable	not specified	none	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)	
MSV000084556	Blanklcms_5.mzXML	blank_analysis	blank_analysis	not applicable	not aplicable	not applicable	not applicable		not applicable	not applicable			United States of America		32.715736|-117.161087	19			Blanklcms_5	2019	not applicable	not specified	none	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)	
MSV000084556	Blanklcms_6.mzXML	blank_analysis	blank_analysis	not applicable	not aplicable	not applicable	not applicable		not applicable	not applicable			United States of America		32.715736|-117.161087	19			Blanklcms_6	2019	not applicable	not specified	none	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)	
MSV000084556	Blanklcms_7.mzXML	blank_analysis	blank_analysis	not applicable	not aplicable	not applicable	not applicable		not applicable	not applicable			United States of America		32.715736|-117.161087	19			Blanklcms_7	2019	not applicable	not specified	none	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)	
MSV000084556	Blanklcms_8.mzXML	blank_analysis	blank_analysis	not applicable	not aplicable	not applicable	not applicable		not applicable	not applicable			United States of America		32.715736|-117.161087	19			Blanklcms_8	2019	not applicable	not specified	none	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)	
MSV000084556	Blanklcms_9.mzXML	blank_analysis	blank_analysis	not applicable	not aplicable	not applicable	not applicable		not applicable	not applicable			United States of America		32.715736|-117.161087	19			Blanklcms_9	2019	not applicable	not specified	none	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)	
MSV000084556	Blanklcms_10.mzXML	blank_analysis	blank_analysis	not applicable	not aplicable	not applicable	not applicable		not applicable	not applicable			United States of America		32.715736|-117.161087	19			Blanklcms_10	2019	not applicable	not specified	none	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)	
MSV000084556	Blanklcms_11.mzXML	blank_analysis	blank_analysis	not applicable	not aplicable	not applicable	not applicable		not applicable	not applicable			United States of America		32.715736|-117.161087	19			Blanklcms_11	2019	not applicable	not specified	none	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)	
MSV000084556	Blanklcms_12.mzXML	blank_analysis	blank_analysis	not applicable	not aplicable	not applicable	not applicable		not applicable	not applicable			United States of America		32.715736|-117.161087	19			Blanklcms_12	2019	not applicable	not specified	none	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)	
MSV000084556	Blanklcms_13.mzXML	blank_analysis	blank_analysis	not applicable	not aplicable	not applicable	not applicable		not applicable	not applicable			United States of America		32.715736|-117.161087	19			Blanklcms_13	2019	not applicable	not specified	none	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)	
MSV000084556	Blanklcms_14.mzXML	blank_analysis	blank_analysis	not applicable	not aplicable	not applicable	not applicable		not applicable	not applicable			United States of America		32.715736|-117.161087	19			Blanklcms_14	2019	not applicable	not specified	none	Q Exactive|MS:1001911	electrospray ionization (positive)		
